{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:58:41Z","timestamp":1790913521331,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T00:00:00Z","timestamp":1779580800000},"content-version":"vor","delay-in-days":143,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101259","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T15:15:07Z","timestamp":1779722107000},"page":"101259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Early-onset hematological toxicity of docetaxel and survival in non-small cell lung cancer patients in the immune checkpoint inhibition era"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5321-0816","authenticated-orcid":false,"given":"M.P.","family":"Kicken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"Grotenhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"de Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.E.E.M.","family":"van den Borne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"de Rouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.H.","family":"van der Leest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.J.M.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.H.","family":"Brinkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.W.G.","family":"van Putten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.J.F.","family":"Franssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.J.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.G.","family":"Lankheet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"Polman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.L.","family":"Krens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Eektimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"van den Heuvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Deenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"ter Heine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2026.101259_bib0001","first-page":"63","article-title":"Docetaxel in the treatment of non-small cell lung carcinoma: an update and analysis","volume":"1","author":"Gubens","year":"2010","journal-title":"Lung Cancer (Auckl.)"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101259_bib0002","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.clgc.2018.05.006","article-title":"Chemotherapy-induced neutropenia and outcome in patients with metastatic castration-resistant prostate cancer treated with first-line Docetaxel","volume":"16","author":"Buttigliero","year":"2018","journal-title":"Clin. Genitourin. Cancer"},{"issue":"10","key":"10.1016\/j.ctarc.2026.101259_bib0003","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1200\/JCO.2000.18.10.2095","article-title":"Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy","volume":"18","author":"Shepherd","year":"2000","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101259_bib0004","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/sj.bjc.6605348","article-title":"Chemotherapy-induced neutropenia as a prognostic factor in advanced non-small-cell lung cancer: results from Japan Multinational Trial Organization LC00-03","volume":"101","author":"Kishida","year":"2009","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101259_bib0005","first-page":"2755","article-title":"Early-onset neutropenia during perioperative chemotherapy is predictive of increased survival in patients with completely resected non-small cell lung cancer: a retrospective analysis","volume":"33","author":"Lee","year":"2013","journal-title":"Anticancer Res."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101259_bib0006","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1111\/bcp.14614","article-title":"Dose individualisation in oncology using chemotherapy-induced neutropenia: example of docetaxel in non-small cell lung cancer patients","volume":"87","author":"Lombard","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101259_bib0007","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.lungcan.2008.03.030","article-title":"Chemotherapy-induced neutropenia as a prognostic factor in patients with advanced non-small cell lung cancer treated with front-line docetaxel-gemcitabine chemotherapy","volume":"62","author":"Pallis","year":"2008","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101259_bib0008","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.annonc.2022.12.013","article-title":"Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Hendriks","year":"2023","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101259_bib0009","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.3390\/curroncol31060258","article-title":"Review of immunotherapy in non-small-cell lung cancer","volume":"31","author":"Capella","year":"2024","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.ctarc.2026.101259_bib0010","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.lungcan.2023.02.002","article-title":"Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer","volume":"178","author":"Auclin","year":"2023","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ctarc.2026.101259_bib0011","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.lungcan.2017.07.034","article-title":"Response rates to single-agent chemotherapy after exposure to immune checkpoint inhibitors in advanced non-small cell lung cancer","volume":"112","author":"Schvartsman","year":"2017","journal-title":"Lung Cancer"},{"issue":"21","key":"10.1016\/j.ctarc.2026.101259_bib0012","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.3390\/cancers15215273","article-title":"Therapeutic resistance models and treatment sequencing in advanced prostate cancer","volume":"15","author":"Schaaf","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101259_bib0013","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/annonc\/mdv129","article-title":"The impact of docetaxel-related toxicities on health-related quality of life in patients with metastatic cancer (QoliTax)","volume":"26","author":"Al-Batran","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ctarc.2026.101259_bib0015","series-title":"Santeon Ziekenhuizen","year":"2024"},{"key":"10.1016\/j.ctarc.2026.101259_bib0017","series-title":"Health Intelligence Platform Santeon (HIPS)","year":"2025"},{"key":"10.1016\/j.ctarc.2026.101259_bib0018","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fphys.2018.00113","article-title":"Neutrophil: a cell with many roles in inflammation or several cell types?","volume":"9","author":"Rosales","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ctarc.2026.101259_bib0019","series-title":"R: a language and environment for statistical computing","year":"2024"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101259_bib0020","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1080\/10543406.2023.2244055","article-title":"Determining the late effect parameter in the fleming-harrington test using asymptotic relative efficiency in cancer immunotherapy clinical trials","volume":"34","author":"Kaneko","year":"2024","journal-title":"J. Biopharm. Stat."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101259_bib0021","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1634\/theoncologist.2008-0190","article-title":"The role of the taxanes in the treatment of older patients with advanced stage non-small cell lung cancer","volume":"14","author":"Ramalingam","year":"2009","journal-title":"Oncologist"},{"issue":"24","key":"10.1016\/j.ctarc.2026.101259_bib0022","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1200\/JCO.24.00733","article-title":"Sacituzumab govitecan versus docetaxel for previously treated advanced or metastatic non-small cell lung cancer: the randomized, open-label phase III EVOKE-01 study","volume":"42","author":"Paz-Ares","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101259_bib0023","doi-asserted-by":"crossref","first-page":"1801100","DOI":"10.1183\/13993003.01100-2018","article-title":"Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer","volume":"52","author":"Cramer-van der Welle","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101259_bib0024","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/00003088-199936020-00002","article-title":"Clinical pharmacokinetics of docetaxel","volume":"36","author":"Clarke","year":"1999","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101259_bib0025","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF02353487","article-title":"A population pharmacokinetic model for docetaxel (Taxotere): model building and validation","volume":"24","author":"Bruno","year":"1996","journal-title":"J. Pharmacokinet. Biopharm."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101259_bib0026","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.ejca.2003.12.026","article-title":"Factors affecting pharmacokinetic variability following doxorubicin and docetaxel-based therapy","volume":"40","author":"Rudek","year":"2004","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101259_bib0028","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1200\/JCO.1998.16.1.187","article-title":"Population pharmacokinetics\/pharmacodynamics of docetaxel in phase II studies in patients with cancer","volume":"16","author":"Bruno","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101259_bib0029","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.2147\/OTT.S85648","article-title":"Efficacy and safety of docetaxel for advanced non-small-cell lung cancer: a meta-analysis of phase III randomized controlled trials","volume":"8","author":"He","year":"2015","journal-title":"Onco Targets. Ther."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246829422600170X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246829422600170X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:47:13Z","timestamp":1790912833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246829422600170X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":26,"alternative-id":["S246829422600170X"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101259","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early-onset hematological toxicity of docetaxel and survival in non-small cell lung cancer patients in the immune checkpoint inhibition era","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101259","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101259"}}